Goldberg GL - Search Results

1

Altered expression of transforming growth factor-beta 1 in cervical neoplasia as an early biomarker in carcinogenesis of the uterine cervix.

Comerci JT Jr, Runowicz CD, Flanders KC, De Victoria C, Fields AL, Kadish AS, Goldberg GL. Comerci JT Jr, et al. Among authors: goldberg gl. Cancer. 1996 Mar 15;77(6):1107-14. Cancer. 1996. PMID: 8635131

2

All-trans retinoic acid and interferon-alpha-2a in patients with metastatic or recurrent carcinoma of the uterine cervix: clinical and pharmacokinetic studies. New York Gynecologic Oncology Group.

Wadler S, Schwartz EL, Haynes H, Rameau R, Quish A, Mandeli J, Gallagher R, Hallam S, Fields A, Goldberg G, McGill F, Jennings S, Wallach RC, Runowicz CD. Wadler S, et al. Cancer. 1997 Apr 15;79(8):1574-80. doi: 10.1002/(sici)1097-0142(19970415)79:8<1574::aid-cncr20>3.0.co;2-u. Cancer. 1997. PMID: 9118041 Clinical Trial.

3

Preliminary phase II clinical and pharmacokinetic study of 9-cis retinoic acid in advanced cervical cancer. New York Gynecologic Oncology Group.

Wadler S, Schwartz EL, Anderson P, Runowicz CD, Chuang L, Del Priore G, Hochster H, Goldberg G, Fields A, Loewen G, Haynes H. Wadler S, et al. Cancer J Sci Am. 1999 May-Jun;5(3):165-70. Cancer J Sci Am. 1999. PMID: 10367173 Clinical Trial.

4

Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study.

Morrison EA, Ho GY, Vermund SH, Goldberg GL, Kadish AS, Kelley KF, Burk RD. Morrison EA, et al. Among authors: goldberg gl. Int J Cancer. 1991 Aug 19;49(1):6-13. doi: 10.1002/ijc.2910490103. Int J Cancer. 1991. PMID: 1874571

5

Single-use percutaneous catheters for intraperitoneal P32 therapy.

Smith HO, Gaudette DE, Goldberg GL, Milstein DM, DeVictoria CL, Runowicz CD. Smith HO, et al. Among authors: goldberg gl. Cancer. 1994 May 15;73(10):2633-7. doi: 10.1002/1097-0142(19940515)73:10<2633::aid-cncr2820731027>3.0.co;2-z. Cancer. 1994. PMID: 8174063

6

Promising new therapies in the treatment of advanced ovarian cancer.

Runowicz CD, Fields AL, Goldberg GL. Runowicz CD, et al. Among authors: goldberg gl. Cancer. 1995 Nov 15;76(10 Suppl):2028-33. doi: 10.1002/1097-0142(19951115)76:10+<2028::aid-cncr2820761320>3.0.co;2-m. Cancer. 1995. PMID: 8634995 Review.

7

Induction of transforming growth factor beta-1 in cervical intraepithelial neoplasia in vivo after treatment with beta-carotene.

Comerci JT Jr, Runowicz CD, Fields AL, Romney SL, Palan PR, Kadish AS, Goldberg GL. Comerci JT Jr, et al. Among authors: goldberg gl. Clin Cancer Res. 1997 Feb;3(2):157-60. Clin Cancer Res. 1997. PMID: 9815667 Clinical Trial.

8

The role of colony-stimulating factor 1 and its receptor in the etiopathogenesis of endometrial adenocarcinoma.

Smith HO, Anderson PS, Kuo DY, Goldberg GL, DeVictoria CL, Boocock CA, Jones JG, Runowicz CD, Stanley ER, Pollard JW. Smith HO, et al. Among authors: goldberg gl. Clin Cancer Res. 1995 Mar;1(3):313-25. Clin Cancer Res. 1995. PMID: 9815987

9

Plasma levels of beta-carotene, lycopene, canthaxanthin, retinol, and alpha- and tau-tocopherol in cervical intraepithelial neoplasia and cancer.

Palan PR, Mikhail MS, Goldberg GL, Basu J, Runowicz CD, Romney SL. Palan PR, et al. Among authors: goldberg gl. Clin Cancer Res. 1996 Jan;2(1):181-5. Clin Cancer Res. 1996. PMID: 9816105

10

Analysis of MDR1 expression in normal and malignant endometrium by reverse transcription-polymerase chain reaction and immunohistochemistry.

Kuo DY, Mallick S, Shen HJ, DeVictoria C, Jones J, Fields AL, Goldberg GL, Runowicz CD, Horwitz SB. Kuo DY, et al. Among authors: goldberg gl. Clin Cancer Res. 1996 Dec;2(12):1981-92. Clin Cancer Res. 1996. PMID: 9816157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

249 results

Search Page